2007
DOI: 10.1590/s1806-37132007000100002
|View full text |Cite
|
Sign up to set email alerts
|

A farmacoeconomia e o tratamento da asma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
1
0
1

Year Published

2013
2013
2017
2017

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 2 publications
0
1
0
1
Order By: Relevance
“…( 71 - 73 ) It is speculated that OSAS plays an important role in asthma exacerbations and that the use of CPAP can decrease exacerbations, improve quality of life, and reduce the number of cases of difficult-to-control asthma. ( 74 ) Chan et al ( 75 ) noted that the mean pre-bronchodilator and post-bronchodilator FEV 1 were higher during CPAP therapy than during two control periods (i.e., without CPAP therapy).…”
Section: Prospects For Intervention In Osas-asthmamentioning
confidence: 99%
See 1 more Smart Citation
“…( 71 - 73 ) It is speculated that OSAS plays an important role in asthma exacerbations and that the use of CPAP can decrease exacerbations, improve quality of life, and reduce the number of cases of difficult-to-control asthma. ( 74 ) Chan et al ( 75 ) noted that the mean pre-bronchodilator and post-bronchodilator FEV 1 were higher during CPAP therapy than during two control periods (i.e., without CPAP therapy).…”
Section: Prospects For Intervention In Osas-asthmamentioning
confidence: 99%
“…( 71 - 73 ) Especula-se que a SAOS pode ser um fator importante nas exacerbações de asma e que o uso de CPAP poderia reduzir as exacerbações, melhorar a qualidade de vida e reduzir o número de casos de asma de difícil controle. ( 74 ) Chan et al ( 75 ) observaram que a média do VEF 1 pré e pós-broncodilatador foi maior durante o intervalo durante a terapia com CPAP quando comparada entre dois períodos sem CPAP.…”
Section: Perspectivas De Intervenção Sobre O Binômio Saos-asmaunclassified